ID   ENOA_RAT                Reviewed;         434 AA.
AC   P04764; Q66HI3; Q6AYV3; Q6P504;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   29-MAY-2024, entry version 210.
DE   RecName: Full=Alpha-enolase;
DE            EC=4.2.1.11 {ECO:0000269|PubMed:8594891};
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 1;
DE   AltName: Full=Non-neural enolase;
DE            Short=NNE;
GN   Name=Eno1; Synonyms=Eno-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Brain, and Liver;
RX   PubMed=2989793; DOI=10.1093/nar/13.12.4365;
RA   Sakimura K., Kushiya E., Obinata M., Takahashi Y.;
RT   "Molecular cloning and the nucleotide sequence of cDNA to mRNA for non-
RT   neuronal enolase (alpha alpha enolase) of rat brain and liver.";
RL   Nucleic Acids Res. 13:4365-4378(1985).
RN   [2]
RP   SEQUENCE REVISION.
RA   Takahashi Y.;
RL   Submitted (JAN-1986) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, Pituitary, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 10-28; 33-50; 72-103; 106-120; 163-179; 184-193;
RP   203-228; 234-262; 270-281; 307-326; 336-394 AND 407-420, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 46-57; 97-109; 245-262 AND 369-382, AND INTERACTION
RP   WITH PLG.
RC   TISSUE=Embryonic brain;
RX   PubMed=7964722; DOI=10.1046/j.1471-4159.1994.63062048.x;
RA   Nakajima K., Hamanoue M., Takemoto N., Hattori T., Kato K., Kohsaka S.;
RT   "Plasminogen binds specifically to alpha-enolase on rat neuronal plasma
RT   membrane.";
RL   J. Neurochem. 63:2048-2057(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 93-153.
RC   TISSUE=Lymphoma;
RA   Bole-Feysot C., Kelly P.A.;
RT   "Rat cDNA encoding alpha enolase (2-phospho-D-glycerate hydro-lyase) (non-
RT   neural enolase) (NNE).";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   DEVELOPMENTAL STAGE, AND CATALYTIC ACTIVITY.
RX   PubMed=8594891; DOI=10.1152/ajpheart.1995.269.6.h1843;
RA   Keller A., Rouzeau J.-D., Farhadian F., Wisnewsky C., Marotte F.,
RA   Lamande N., Samuel J.L., Schwartz K., Lazar M., Lucas M.;
RT   "Differential expression of alpha- and beta-enolase genes during rat heart
RT   development and hypertrophy.";
RL   Am. J. Physiol. 269:H1843-H1851(1995).
RN   [8]
RP   INDUCTION.
RX   PubMed=10662718; DOI=10.1152/ajpendo.2000.278.2.e330;
RA   Merkulova T., Keller A., Oliviero P., Marotte F., Samuel J.L.,
RA   Rappaport L., Lamande N., Lucas M.;
RT   "Thyroid hormones differentially modulate enolase isozymes during rat
RT   skeletal and cardiac muscle development.";
RL   Am. J. Physiol. 278:E330-E339(2000).
RN   [9]
RP   SUBCELLULAR LOCATION OF ALPHA/GAMMA HETERODIMER.
RX   PubMed=15041191; DOI=10.1016/j.neures.2003.12.006;
RA   Ueta H., Nagasawa H., Oyabu-Manabe Y., Toida K., Ishimura K., Hori H.;
RT   "Localization of enolase in synaptic plasma membrane as an alphagamma
RT   heterodimer in rat brain.";
RL   Neurosci. Res. 48:379-386(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE SPECIFICITY.
RX   PubMed=19423663; DOI=10.1530/rep-09-0052;
RA   Khan S.A., Suryawanshi A.R., Ranpura S.A., Jadhav S.V., Khole V.V.;
RT   "Identification of novel immunodominant epididymal sperm proteins using
RT   combinatorial approach.";
RL   Reproduction 138:81-93(2009).
CC   -!- FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-
CC       phosphoglycerate to phosphoenolpyruvate. In addition to glycolysis,
CC       involved in various processes such as growth control, hypoxia tolerance
CC       and allergic responses. May also function in the intravascular and
CC       pericellular fibrinolytic system due to its ability to serve as a
CC       receptor and activator of plasminogen on the cell surface of several
CC       cell-types such as leukocytes and neurons. Stimulates immunoglobulin
CC       production. {ECO:0000250|UniProtKB:P06733}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289,
CC         ChEBI:CHEBI:58702; EC=4.2.1.11;
CC         Evidence={ECO:0000269|PubMed:8594891};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10165;
CC         Evidence={ECO:0000305|PubMed:8594891};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P06733};
CC       Note=Binds two Mg(2+) per subunit. Required for catalysis and for
CC       stabilizing the dimer. {ECO:0000250|UniProtKB:P06733};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5. {ECO:0000305|PubMed:8594891}.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits, alpha,
CC       beta and gamma, which can form homodimers or heterodimers which are
CC       cell-type and development-specific (By similarity). ENO1 interacts with
CC       PLG in the neuronal plasma membrane and promotes its activation. The C-
CC       terminal lysine is required for this binding (PubMed:7964722).
CC       Interacts with ENO4 and PGAM2 (By similarity). Interacts with CMTM6 (By
CC       similarity). {ECO:0000250|UniProtKB:P06733,
CC       ECO:0000250|UniProtKB:P17182, ECO:0000269|PubMed:7964722}.
CC   -!- INTERACTION:
CC       P04764; Q5VU43-11: PDE4DIP; Xeno; NbExp=2; IntAct=EBI-915852, EBI-10769071;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Note=Can translocate to
CC       the plasma membrane in either the homodimeric (alpha/alpha) or
CC       heterodimeric (alpha/gamma) form.
CC   -!- TISSUE SPECIFICITY: Expressed in flagella of epididymal sperm. The
CC       alpha/alpha homodimer is expressed in embryo and in most adult tissues.
CC       The alpha/beta heterodimer and the beta/beta homodimer are found in
CC       striated muscle, and the alpha/gamma heterodimer and the gamma/gamma
CC       homodimer in neurons. {ECO:0000269|PubMed:19423663}.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition from the
CC       alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle
CC       cells, and to the alpha/gamma heterodimer in nerve cells. In brain,
CC       levels of ENO1 decrease around 10 dpc and then gradually increase to
CC       adult age. In embryonic heart, ENO1 levels decrease rapidly during
CC       cardiac development. {ECO:0000269|PubMed:2989793,
CC       ECO:0000269|PubMed:8594891}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P06733}.
CC   -!- PTM: Lysine 2-hydroxyisobutyrylation (Khib) by p300/EP300 activates the
CC       phosphopyruvate hydratase activity. {ECO:0000250|UniProtKB:P06733}.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63174.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02610; CAA26456.1; -; mRNA.
DR   EMBL; BC063174; AAH63174.1; ALT_INIT; mRNA.
DR   EMBL; BC078896; AAH78896.1; -; mRNA.
DR   EMBL; BC081847; AAH81847.2; -; mRNA.
DR   EMBL; AF241613; AAK01319.1; -; mRNA.
DR   PIR; A23126; A23126.
DR   RefSeq; NP_001103378.1; NM_001109908.1.
DR   RefSeq; NP_036686.2; NM_012554.3.
DR   AlphaFoldDB; P04764; -.
DR   SMR; P04764; -.
DR   BioGRID; 246510; 4.
DR   IntAct; P04764; 10.
DR   MINT; P04764; -.
DR   STRING; 10116.ENSRNOP00000073191; -.
DR   MoonProt; P04764; -.
DR   GlyGen; P04764; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P04764; -.
DR   PhosphoSitePlus; P04764; -.
DR   SwissPalm; P04764; -.
DR   jPOST; P04764; -.
DR   PaxDb; 10116-ENSRNOP00000024106; -.
DR   Ensembl; ENSRNOT00000081579.2; ENSRNOP00000073191.1; ENSRNOG00000017895.8.
DR   Ensembl; ENSRNOT00055026761; ENSRNOP00055021685; ENSRNOG00055015695.
DR   Ensembl; ENSRNOT00060044686; ENSRNOP00060037039; ENSRNOG00060025698.
DR   Ensembl; ENSRNOT00065018506; ENSRNOP00065014146; ENSRNOG00065011372.
DR   GeneID; 24333; -.
DR   KEGG; rno:24333; -.
DR   UCSC; RGD:2553; rat.
DR   AGR; RGD:2553; -.
DR   CTD; 2023; -.
DR   RGD; 2553; Eno1.
DR   eggNOG; KOG2670; Eukaryota.
DR   GeneTree; ENSGT00950000182805; -.
DR   InParanoid; P04764; -.
DR   OrthoDB; 1093250at2759; -.
DR   PhylomeDB; P04764; -.
DR   TreeFam; TF300391; -.
DR   BRENDA; 4.2.1.11; 5301.
DR   SABIO-RK; P04764; -.
DR   UniPathway; UPA00109; UER00187.
DR   PRO; PR:P04764; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000017895; Expressed in adult mammalian kidney and 18 other cell types or tissues.
DR   ExpressionAtlas; P04764; baseline and differential.
DR   GO; GO:0005938; C:cell cortex; IDA:CAFA.
DR   GO; GO:0009986; C:cell surface; IDA:CAFA.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0030426; C:growth cone; IDA:CAFA.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:CAFA.
DR   GO; GO:0005640; C:nuclear outer membrane; ISO:RGD.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; IDA:CAFA.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0051020; F:GTPase binding; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:RGD.
DR   GO; GO:0061621; P:canonical glycolysis; IDA:CAFA.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:CAFA.
DR   GO; GO:0098761; P:cellular response to interleukin-7; ISO:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:CAFA.
DR   GO; GO:0006094; P:gluconeogenesis; ISO:RGD.
DR   GO; GO:0006096; P:glycolytic process; IDA:CAFA.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:1903298; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:2001171; P:positive regulation of ATP biosynthetic process; ISO:RGD.
DR   GO; GO:0045933; P:positive regulation of muscle contraction; ISO:RGD.
DR   GO; GO:0010756; P:positive regulation of plasminogen activation; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; Enolase-like C-terminal domain; 1.
DR   Gene3D; 3.30.390.10; Enolase-like, N-terminal domain; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR036849; Enolase-like_C_sf.
DR   InterPro; IPR029017; Enolase-like_N.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   NCBIfam; TIGR01060; eno; 1.
DR   PANTHER; PTHR11902:SF58; ALPHA-ENOLASE; 1.
DR   PANTHER; PTHR11902; ENOLASE; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDS00001; Enolase; 1.
DR   SFLD; SFLDF00002; enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; Enolase C-terminal domain-like; 1.
DR   SUPFAM; SSF54826; Enolase N-terminal domain-like; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Cytoplasm; Direct protein sequencing;
KW   Glycolysis; Hydroxylation; Isopeptide bond; Lyase; Magnesium; Membrane;
KW   Metal-binding; Phosphoprotein; Plasminogen activation; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   CHAIN           2..434
FT                   /note="Alpha-enolase"
FT                   /id="PRO_0000134099"
FT   REGION          405..434
FT                   /note="Required for interaction with PLG"
FT                   /evidence="ECO:0000269|PubMed:7964722"
FT   ACT_SITE        210
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         40
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         158
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         167
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         293
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         318
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         370..373
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         394
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         44
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         60
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         64
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         71
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         202
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         228
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         228
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         228
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         233
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         256
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         281
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         281
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         285
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         287
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         343
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         406
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         420
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         420
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         420
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   CONFLICT        48
FT                   /note="E -> Q (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93..96
FT                   /note="LMIE -> DQIK (in Ref. 6; AAK01319)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        125
FT                   /note="E -> G (in Ref. 1; CAA26456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        144
FT                   /note="I -> T (in Ref. 1; CAA26456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151
FT                   /note="N -> D (in Ref. 6; AAK01319)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        250
FT                   /note="E -> Q (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="G -> E (in Ref. 1; CAA26456)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   434 AA;  47128 MW;  736660B2D5E936DC CRC64;
     MSILKIHARE IFDSRGNPTV EVDLYTAKGL FRAAVPSGAS TGIYEALELR DNDKTRFMGK
     GVSKAVEHIN KTIAPALVSK KLNVVEQEKI DQLMIEMDGT ENKSKFGANA ILGVSLAVCK
     AGAVEKGVPL YRHIADLAGN PEVILPVPAF NVINGGSHAG NKLAMQEFMI LPVGASSFRE
     AMRIGAEVYH NLKNVIKEKY GKDATNVGDE GGFAPNILEN KEALELLKSA IAKAGYTDQV
     VIGMDVAASE FYRAGKYDLD FKSPDDASRY ITPDQLADLY KSFIKDYPVV SIEDPFDQDD
     WDAWQKFTAT AGIQVVGDDL TVTNPKRIAK AAGEKSCNCL LLKVNQIGSV TESLQACKLA
     QSNGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQI LRIEEELGSK
     AKFAGRSFRN PLAK
//
